Prestige Biologics Co., Ltd. (KOSDAQ:334970)
1,892.00
-24.00 (-1.25%)
At close: Jul 7, 2026
-54.41% (1Y)
| Market Cap | 147.11B -50.1% |
| Revenue (ttm) | 18.03B +168.6% |
| Net Income | -35.42B |
| EPS | -410.69 |
| Shares Out | 77.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 78,996 |
| Open | 1,929.00 |
| Previous Close | 1,916.00 |
| Day's Range | 1,840.00 - 1,949.00 |
| 52-Week Range | 1,650.00 - 5,220.00 |
| Beta | 0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |